Health Biocon Drug Itolizumab Gets Government Approval As COVID-19 Medication In India Aanchal Singh Jul 14, 2020 Biocon drug Itolizumab has received clearance from the Drugs Controller General of India for treating moderate to severe COVID-19 patients.
